American Committee for Shaare Zedek Medical Center

In its mission statement, Shaare Zedek (http://www.acsz.org/)
states that “For more than a century, Shaare Zedek Medical
Center in Jerusalem, a 500-bed facility located in the center of
the city, has been known as the Hospital with a Heart. Patients
have consistently streamed to our hospital, seeking top level
treatment in a compassionate, supportive and nurturing environment.
Today, while our reputation as the most exceptional hospital
for health care treatment continues to grow, Shaare Zedek has taken
its commitment to its patients to the next level by providing industry
leading, cutting-edge medical care. From the most advanced
procedures in Laparoscopic Surgery to the latest technology in
robotics, from the treating of victims of terror and IDF soldiers,
to expectant mothers needing advanced prenatal care; from
seniors with tragic illnesses like Alzheimer’s disease, to cancer
patients fighting for their lives, we provide a full range of services
at the highest level to every patient who walks through our doors.”

Shaare Zedek is a public non-profit hospital that accommodates
more than 60,000 emergency visits per year. In 2004, it completed
a new ER that was three times the size of its previous ER. 40% of
those injured in terrorist attacks in Jerusalem were treated at
Shaare Zedek. It also has 125,000 outpatient visits per year and
40,000 admissions. And, it is a major employer in the city
employing over 2,000 people.

Charity Navigator (http://www.charitynavigator.org/),
America’s leading charity evaluator, has given the American
Committee for Shaare Zedek Medical Center in Jerusalem an
overall three star rating (four stars is the highest rating.)
Its organizational efficiency rating is one star as it
spends 70% of its funds on program expenses, 9% on
administrative expenses, and 21% on fundraising expenses. Its
organizational capacity (the ability to sustain itself) rating
is four stars based on primary revenue growth of 20%, primary
expenses growth of 7%, and a working capital ratio of 2.27 years
(it can sustain itself for 2.27 years without any further contributions.)

Based on its 2005 income statement, it operated with an excess of
$4,310,155. It had net assets of $23,727,004. Its national
executive director, Paul Glasser, received a salary of $212,019
which is 1.56% of the total expenses.

Next week's blog: Israel Cancer Research Fund